Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer By Ogkologos - April 16, 2026 4 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a phase III study in patients recruited through the PATCH and STAMPEDE-1 trial networks Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Indications for Selpercatinib Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated Advanced KRAS p.G12D-mutated NSCLC and PADC MOST POPULAR Paramedical Tattoo Artist Creates Realistic Nipple Tattoos For Breast Cancer Survivors... May 21, 2019 24-Year-Old Diagnosed With Breast Cancer After Doctors Said Her Chest Was... January 27, 2020 FDA Approves Carfilzomib and Daratumumab with Dexamethasone for Multiple Myeloma August 24, 2020 EMA Recommends Extension of Therapeutic Indications for Retifanlimab February 6, 2026 Load more HOT NEWS Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women... PICOS Score May Help in Identification of Patients with Brain Metastasis... Resource Round-Up: Let’s Win Pancreatic Cancer FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο
